Made possible by a charitable contribution from Bayer
Navigation Tip: Click on blue text that’s italicized, underlined and in bold for link to more information.
We hope that you’re doing well and off to a great start in 2019! Article titles for PROSTATE CANCER NEWS YOU CAN USE are listed below along with a link to the Us TOO web page that provides access to the full text for each article.
Video is now available from the Us TOO Prostate Cancer Pathways for Patients and Caregivers Chicago event and webcast! The event was recorded on November 3 at NorthShore University HealthSystem in Skokie, IL. There are special presentations on Sex and Intimacy after Treatment, and Pelvic Floor Health for Incontinence in addition to great information about men's health risks, PSA testing, active surveillance, treatment options, and management of treatment side effects. Video content is archived to provide direct access to short video segments specific to each topic, in addition to the option of watching the entire presentation.
If you are the wife or female partner of a man with prostate cancer, we invite you to join a conference call to connect with other women facing the same challenges. Because prostate cancer is a couple's disease, the woman is often subject to her own concerns in addition to those she shares with her partner. A Forum for Her is an ongoing series of conference calls that provides women with important peer-to-peer support. January calls are scheduled for noon Central Time on 1/23 and 1/30. To register email firstname.lastname@example.org or call 877-978-7866.
Have you seen the Hot SHEET supplement Between the Sheets? It's a regular column dealing with sex and intimacy after treatment for prostate cancer, with questions answered by experts. Read previous issues and submit your question for possible publication at ustooBTS@ustoo.org.
As you may know, Us TOO collaborates with the Patient Access Network (PAN) Foundation, an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications. This includes financial assistance for patients with advanced prostate cancer. To do so more efficiently, PAN is introducing FundFinder, a new web-based app that instantly notifies users when a disease fund opens at any charitable foundation. Register online to receive notifications from FundFinder.
The Us TOO Prostate Cancer Clinical Trial Finder simplifies the process of identifying clinical trials by matching a patient’s profile with relevant clinical trials at no charge. Patient information can be entered online or on the phone by calling a toll-free number to talk with clinical trial navigators who speak English or Spanish!
NEWS YOU CAN USE ARTICLES:
Please note that the content below lists only the title of the article rather than a direct link to the content. Get access to full articles.
Mayo Clinic discovers biological markers that could guide treatment for prostate cancer
Prostate cancer scoring method may underestimate mortality risk in black men
Surgery unnecessary for many prostate cancer patients
New Prostate Cancer Findings Has Been Reported by Investigators at Memorial Sloan-Kettering Cancer Center (Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer)
Researchers use computer model to predict prostate cancer progression
Findings in the Area of Prostate Cancer Reported from University Health Network (Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatment)
Whole-body PET/MRI provides one-stop shop for staging high-risk prostate cancer patients
Proximity to muscle cells may promote spread of prostate cancer cells, NIH study suggests
Findings from University of Calgary Provides New Data about Prostate Cancer (Impact of Prior Local Treatment on the Outcomes of Metastatic Hormone-Sensitive Prostate Cancer: Secondary Analysis of a Randomized Controlled Trial)
CWRU researcher awarded nearly $1 million from the DOD to study prostate cancer drug resistance
New Prostate Cancer Data Have Been Reported by Researchers at University of California - San Francisco (Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials)
Investigators at Yale University Describe Findings in Prostate Cancer (Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States)
New Prostate-Specific Antigen Study Results Reported from Sao Paulo State University (Using an Electrochemical Aptasensor to Early Detect Prostate Specific and Free Prostate Specific Antigens Released by Cancer Cells)
Reports on Prostate Cancer Findings from University of California Provide New Insights (Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer)
CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer
Take care, stay warm, and watch for the February 2019 issue of the Us TOO Hot SHEET newsletter later this month. Let us know how we can help provide you with educational resources, support services and personal connections to others in the prostate cancer community.
All the best,
Chuck Strand, Chief Executive Officer
Jackie Konieczka, Office Manager
Terri Likowski, Program Director - Support Group Services